No Detail Found!

Effectiveness of Platelet Rich Plasma for the Management of Knee Osteoarthritis: A Randomized Placebo Controlled Trial

Author(s)
ADNAN QAMAR Shaikh Zayed Federal Postgraduate Medical Institute,Lahore, Pakistan
SAIMA NAZ MOHSIN National Health Research Complex Shaikh Zayed Medical Complex Lahore, Pakistan
UZMA NASIM SIDDIQUI Department of Medicine, Shaikh Zayed Federal Postgraduate Medical Institute,Lahore,Pakistan
SANA NAZ Department of Community Medicine, Shalamar Medical and Dental College,Lahore, Pakistan
SANA DANISH Department of Obstetrics & Gynaecology, Shaikh Zayed Federal Postgraduate Medical Institute,Lahore,Pakistan
Abstract
Aim: To determine impact of platelet rich plasma therapy for the management of knee osteoarthritis. Study design: Prospective double-blinded, add -on randomized, placebo-controlled trial Place and duration of study: Department of Orthopedics, Shaikh Zayed Hospital Lahore from 1st January 2019 to 30th June 2019 Methodology: Fifty volunteer participants fulfilling inclusion criteria were enrolled. One hundred knees of patients were randomly allocated into two groups. Knees were assigned either of the two groups. Platelet rich plasma group which was assigned to receive 5ml of platelet rich plasma and normal saline (NS) group which was assigned to receive 5ml of NS labeled as control group. All patients given 3 successive intra-articular injections of 5 mL of autologous platelet rich plasma or 5ml of normal saline was given at weekly intervals. Patients were blinded and subjected to a standardized injection protocol and the intensity of pain was assessed on visual analog scale (VAS) for pain. Results: The VAS scores decreased from 50.9±14.7 at baseline assessment to 43.6±16.2 at 1-month follow-up after completion of therapy for PRP group (p<0.0203). The improvement was maintained from the end of the therapy to 3 and 6 months' follow-up, as measure of VAS score as 30.54±11.8 and 20.2±8.6 respectively (p<0.0001). In normal saline group, there was very slight decrease in VAS score from baseline i.e. 49.8±19.5 to 48±22.7, 44±16.6, and 42±21.7 at 1, 3 and 6 months interval. Conclusion: Platelet rich plasma therapy can provide effective pain control up to 6 months post injection in knee osteoarthritis.
Publication Details
Page(s) 1553-1556
Published Journal: Pakistan Journal of Medical and Health Sciences, Volume: 15, Issue: 7, Year: 2021

Request the full text from PASTIC

Keywords
Platelet Rich Plasma (PRP), pain score, Knee osteoarthritis (OA)
0

Citations

0

Downloads

78

Views